Brussels, 21/03/2001 (Agence Europe) - The European Parliament debate, last week in Strasbourg, and the confirmation by Commissioner Pascal Lamy of the position held by the Community executive in favour of the use by the most poor countries of the system of obligatory licences for the local manufacturing of anti-viral drugs seems to have contributed towards causing a reaction from the World Health Organisation (WHO) and the World Trade Organisation (WTO). The two organisations have announced...